SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Brazilian election developments and relief over Nu Holdings statement that it is not pursuing a Monzo deal are driving discussion of the rebound. Traders are hopeful the recovery continues, while others doubt the move will hold and frame it as a short squeeze.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Toshibas plan to expand hard-disk capacity for AI data centers has sparked concern that added supply could challenge Western Digitals market share and pricing power, driving a sharp selloff in WDC and Seagate. Traders are divided: many call the reaction excessive because the expansion will take time and HDD demand remains strong, while others see a credible medium-term competitive risk.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Sam Altmans statement that OpenAI remains closely engaged with Cerebras has reassured traders after a report raised concerns that OpenAIs latest Ultrafast mode would rely on Nvidia GPUs instead. Bulls see the comments as reaffirming the partnership, while others remain cautious about insider share unlocks and selling pressure.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is drawing attention for its role in meeting AI data-center power demand, with traders focused on Oracles reaffirmed Project Jupiter fuel-cell commitment and Blooms ability to scale onsite power deployments. Bulls see strong demand and growth potential, while skeptics cite execution risks around the project, high valuation, and sharp share-price swings.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus ARCT-810 Phase 2 update for OTC deficiency and unveiling of its LUNAR 2.0 delivery platform are driving discussion, alongside plans to add ARCT-2601 and acquire myNEO. Many traders view the clinical findings and platform progress positively, while others question the delayed timelines and added spending and say the update fell short of expectations.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL ovarian-cancer update reporting an estimated 48% three-year survival has drawn attention, with traders highlighting the durable result and potential regulatory relevance. Others caution that the data come from a small, nonrandomized Phase 1b cohort and question whether they support FDA action, while some characterize the share-price reaction as sell the news.

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in West Palm Beach, FL.

Stablecoin Development Corp.

SDEVs sharp, high-volume rally is drawing momentum-trading attention, with traders speculating about a low-float short squeeze and linking the move to gains in SKY, the token held in the companys treasury. Others say the surge lacks a confirmed company catalyst and warn about potential dilution and a sharp reversal.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX momentum is driving attention, especially a record Alloy Kore design win for the Coretura vehicle platform, a newly disclosed Uber design win, and stronger results with raised guidance. Many traders see these developments as evidence of growth in software-defined vehicles and physical AI, while others question how quickly the wins will translate into revenue and have debated the stocks volatile, sometimes muted reaction.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedixs strong Q2 results and DaVita agreement have not eased concern that DefenCath revenue could weaken after the TDAPA payment transition; traders are debating whether future CMS reimbursement, Medicare Advantage access and broader uptake can offset that risk. Frustration over the share-price response contrasts with optimism about REZZAYOs potential and upcoming regulatory and clinical milestones.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydances Warner Bros. Discovery merger and the related NYSE relisting and shareholder warrant distribution dominate discussion. Traders are divided: some see the combined content library and potential synergies as a growth opportunity, while others point to heavy debt, dilution and financing costs as reasons for the stocks weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?

electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of +19.51% and +0.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -3.30% and +14.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

electroCore Q1 Earnings Call Highlights

electroCore (NASDAQ:ECOR) executives highlighted record quarterly revenue, expanding margins, and continued progress toward profitability during the company's first-quarter 2026 earnings call, while also discussing a leadership transition and commercial priorities across federal and consumer channel...

electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of -0.86% and +7.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Insider Selling: electroCore (NASDAQ:ECOR) Director Sells 16,072 Shares of Stock

electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of electroCore stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $6.02, for a total value of $96,753.44. Following the sale, the director directly owned 291,471...

electroCore (NASDAQ:ECOR) Director Daniel Goldberger Sells 16,072 Shares

electroCore, Inc. (NASDAQ:ECOR - Get Free Report) Director Daniel Goldberger sold 16,072 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $6.02, for a total transaction of $96,753.44. Following the sale, the director owned...

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

electroCore (ECOR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Analysts Offer Predictions for electroCore FY2030 Earnings

electroCore, Inc. (NASDAQ:ECOR - Free Report) - Equities researchers at HC Wainwright lifted their FY2030 earnings per share estimates for shares of electroCore in a research note issued to investors on Friday, March 20th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.

ElectroCore Inc

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Current Price	$10.14
Prev Close	$10.32
Open	$10.47
Dividend Yield	0.00%
50-Day Moving Average	$9.34
Beta	1.09
Avg. Volume	84,523.09
PE Ratio	-5.98

52-Week High	$12.70
52-Week Low	$4.41
Market Capitalization	$91.42M
EPS (Annual)	-$1.65
Price to Book	-32.72
Revenue Per Employee	$385,927.71

Feed

News

Sentiment

Earnings

Fundamentals

Info

ECOR Fundamentals